EUVIMEDEUVIMED entdecken
Open Access

Extremely Late Local Recurrence of a Choroidal Melanoma, 51 Years Following Cobalt-60 Plaque Radiation Therapy

Gabriel Damien Verdon iD, Ann Schalenbourg, Alessia Pica

Klinische Monatsblätter für Augenheilkunde · 01.04.2026 · 243 (04) · 512-515

DOI: 10.1055/a-2793-7860 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Klinische Monatsblätter für Augenheilkunde, erschienen am 01.04.2026. Verfasst von Gabriel Damien Verdon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology - FAA - University of Lausanne, University Eye Hospital Jules Gonin, Lausanne, Switzerland. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Conservative radiation therapy of uveal melanoma has a long history, the first successfully treated case being reported by Deutschmann [ 1 ]. In 1913, he applied mesothorium, a natural isotope, to an only eye, resulting 7 months later in flat tumor scar. In 1929, Foster-Moore was the first to insert radon needles (“Curie-puncture”) into the choroidal melanoma, resulting in its regression [ 1 ], [ 2 ]. In 1948, it was Stallard who developed episcleral radio-active plaques, using the synthetic isotope, Cobalt-60, emitting a bidirectional, strong gamma irradiation [ 1 ], [ 2 ]. Subsequently, since 1968 and 1975 respectively, Ruthenium-106 and Iodine-125 plaques were introduced, offering a more localized irradiation, and reduced exposure to both the orbital structures of the patient and the hands of the medical staff [ 1 ], [ 3 ]. In 1975, Gragoudas treated the first patient with external beam proton therapy, providing a conservative alternative to patients with tumors inaccessible to brachytherapy, as well as an excellent local tumor control [ 1 ], [ 4 ]. In 2006, the COMS study gave an answer to a long-standing controversy, by demonstrating that the metastatic risk was not higher in uveal melanoma patients treated with conservative (Iodine-125) radiation therapy than in those managed with enucleation [ 5 ]. However, in 2016, the Ophthalmic Oncology Task Force insisted on the importance of local tumor control, the hazard ratio (HR) of developing metastases being 6.28 in case of a local recurrence following conservative treatment [ 6 ]. We report the exceptional case of a recurrent choroidal melanoma, 51,5 years following Cobalt-60 brachytherapy, which we re-treated with conservative proton therapy. One year later, the tumor has regressed and the patient has no metastases. Publication History Received: 03 November 2025 Accepted: 20 January 2026 Article published online: 17 March 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Autor:innen und Institutionen

  • Ophthalmology - FAA - University of Lausanne, University Eye Hospital Jules Gonin, Lausanne, Switzerland.
  • Center for Proton Therapy - ETH Domain, Paul Scherrer Institut, Villigen, Switzerland.

ORCID-Profile: Gabriel Damien Verdon

Zitieren

APA

Verdon, G. D., Schalenbourg, A., & Pica, A. (2026). Extremely Late Local Recurrence of a Choroidal Melanoma, 51 Years Following Cobalt-60 Plaque Radiation Therapy. Klinische Monatsblätter für Augenheilkunde, 243(04), 512-515. https://doi.org/10.1055/a-2793-7860

Vancouver

Verdon GD, Schalenbourg A, Pica A. Extremely Late Local Recurrence of a Choroidal Melanoma, 51 Years Following Cobalt-60 Plaque Radiation Therapy. Klinische Monatsblätter für Augenheilkunde. 2026;243(04):512-515. doi:10.1055/a-2793-7860

BibTeX
@article{Verdon2026,
  author = {Verdon, Gabriel Damien and Schalenbourg, Ann and Pica, Alessia},
  title = {Extremely Late Local Recurrence of a Choroidal Melanoma, 51 Years Following Cobalt-60 Plaque Radiation Therapy},
  journal = {Klinische Monatsblätter für Augenheilkunde},
  year = {2026},
  volume = {243},
  number = {04},
  pages = {512--515},
  doi = {10.1055/a-2793-7860}
}
Kostenlos starten →